Viking Therapeutics (VKTX 15.16%) is a healthcare company that possesses a lot of growth potential. And last year, its shares rose by 116%, as investors were bullish on its prospects.This year, however, has been a much different story, with the markets on shaky ground. Viking has lost more than 40% of its value since January.While there has been some significant volatility in the short term, there could still be a lot more room for Viking to be a much more valuable business in the long run, especially if it ...